Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Pierer Mobility, Valneva, Andritz, Rosenbauer, Frequentis (10/01/2024)

14.01.2024

Pierer Mobility: Pierer Mobility, a holding company of Europe’s leading manufacturer of powered two-wheelers, producing a full range of premium brands including KTM, GASGAS and Husqvarna Motorcycles, expects consolidated sales of between EUR 2,650 million and EUR 2,670 million for the 2023 financial year, which represents an increase of around 9 % compared to the previous year. The Group increased motorcycle sales in the 2023 financial year to 381,634 units sold (+2 %). In Europe, sales totalled around 140,000 motorcycles and around two thirds of motorcycles (around 240,000) were sold in markets outside Europe, particularly in North America, India and Australia. The Bicycle Division also increased sales by around 33 % and sold 157,358 e-bicycles & bicycles (previous year: 118,465).
Pierer Mobility: weekly performance: 3.52%

Valneva: Specialty vaccine company Valneva announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of two different dose levels of Valneva’s single-shot chikungunya vaccine. Juan Carlos Jaramillo, Chief Medical Officer of Valneva, said, “This pediatric trial is extremely important. Given the significant threat that chikungunya poses to individuals living in or traveling to endemic areas, it is crucial to make the vaccine accessible to all age groups. By doing so, we can broaden the protection against and reduce the impact of this debilitating disease.” There is currently no approved chikungunya vaccine for children and Valneva’s vaccine IXCHIQ® is currently the only licensed chikungunya vaccine to address this unmet medical need in adults aged 18 years and older who are at increased risk of exposure to the virus. Once available, the Phase 2 pediatric data are intended to support a Phase 3 pivotal study in children with the objective to extend the label in this age group following initial regulatory approvals in adults and possibly in adolescents.
Valneva: weekly performance: -10.00%

Andritz: International technology group Andritz has retrofitted two selective catalytic reduction systems (SCR) at the Leverkusen Chemical Park, Germany, significantly contributing to the park’s rapid revitalization after a devastating explosion in 2021. After the incident, which led to the shutdown of all four lines of the hazardous waste treatment plant, Currenta GmbH & Co OHG, the operator of the chemical park, commissioned Andritz to retrofit the severly damaged SCR II. However, unexpected corrosion damages at the SCR I unit made it necessary to put this unit out of service as well. Andritz proposed a  concept that minimized downtime and allowed for the earliest possible restart of both units.
Andritz: weekly performance: 0.65%

Rosenbauer: Against the backdrop of the restructuring of the Rosenbauer Group, which has been ongoing since the previous year, the Supervisory Board and Chief Technology Officer Daniel Tomaschko have agreed to terminate his contract with effect from today. CEO Sebastian Wolf will temporarily take over the technical agendas until a successor is found.
Rosenbauer: weekly performance: 2.34%

Frequentis: Frequentis Defense has successfully completed trials of its fixed and deployable digital tower for the United States Department of Defense (DoD). Trials took place at Homestead Air Reserve Base, Florida; Moody Air Force Base, Georgia; and Naval Air Station Corpus Christi, Texas to prove the operational feasibility and benefits of the system for military personnel. "We think the future is bright for the remote digital tower. We continue to do assessments of this technology; we continue to be impressed with it. We do believe it has benefits, particularly where we don’t have to put the controllers in the tower, keeping them out of harms way,” noted Ed Wright, Executive Director, Headquarters US Air Force Flight Standards Agency, US DoD.
Frequentis: weekly performance: -2.19%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (10/01/2024)


Partners









latest 21st Austria

21st Austria weekly - Pierer Mobility, Valneva, Andritz, Rosenbauer, Frequentis (10/01/2024)


14.01.2024, 4026 Zeichen



Pierer Mobility: Pierer Mobility, a holding company of Europe’s leading manufacturer of powered two-wheelers, producing a full range of premium brands including KTM, GASGAS and Husqvarna Motorcycles, expects consolidated sales of between EUR 2,650 million and EUR 2,670 million for the 2023 financial year, which represents an increase of around 9 % compared to the previous year. The Group increased motorcycle sales in the 2023 financial year to 381,634 units sold (+2 %). In Europe, sales totalled around 140,000 motorcycles and around two thirds of motorcycles (around 240,000) were sold in markets outside Europe, particularly in North America, India and Australia. The Bicycle Division also increased sales by around 33 % and sold 157,358 e-bicycles & bicycles (previous year: 118,465).
Pierer Mobility: weekly performance: 3.52%

Valneva: Specialty vaccine company Valneva announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of two different dose levels of Valneva’s single-shot chikungunya vaccine. Juan Carlos Jaramillo, Chief Medical Officer of Valneva, said, “This pediatric trial is extremely important. Given the significant threat that chikungunya poses to individuals living in or traveling to endemic areas, it is crucial to make the vaccine accessible to all age groups. By doing so, we can broaden the protection against and reduce the impact of this debilitating disease.” There is currently no approved chikungunya vaccine for children and Valneva’s vaccine IXCHIQ® is currently the only licensed chikungunya vaccine to address this unmet medical need in adults aged 18 years and older who are at increased risk of exposure to the virus. Once available, the Phase 2 pediatric data are intended to support a Phase 3 pivotal study in children with the objective to extend the label in this age group following initial regulatory approvals in adults and possibly in adolescents.
Valneva: weekly performance: -10.00%

Andritz: International technology group Andritz has retrofitted two selective catalytic reduction systems (SCR) at the Leverkusen Chemical Park, Germany, significantly contributing to the park’s rapid revitalization after a devastating explosion in 2021. After the incident, which led to the shutdown of all four lines of the hazardous waste treatment plant, Currenta GmbH & Co OHG, the operator of the chemical park, commissioned Andritz to retrofit the severly damaged SCR II. However, unexpected corrosion damages at the SCR I unit made it necessary to put this unit out of service as well. Andritz proposed a  concept that minimized downtime and allowed for the earliest possible restart of both units.
Andritz: weekly performance: 0.65%

Rosenbauer: Against the backdrop of the restructuring of the Rosenbauer Group, which has been ongoing since the previous year, the Supervisory Board and Chief Technology Officer Daniel Tomaschko have agreed to terminate his contract with effect from today. CEO Sebastian Wolf will temporarily take over the technical agendas until a successor is found.
Rosenbauer: weekly performance: 2.34%

Frequentis: Frequentis Defense has successfully completed trials of its fixed and deployable digital tower for the United States Department of Defense (DoD). Trials took place at Homestead Air Reserve Base, Florida; Moody Air Force Base, Georgia; and Naval Air Station Corpus Christi, Texas to prove the operational feasibility and benefits of the system for military personnel. "We think the future is bright for the remote digital tower. We continue to do assessments of this technology; we continue to be impressed with it. We do believe it has benefits, particularly where we don’t have to put the controllers in the tower, keeping them out of harms way,” noted Ed Wright, Executive Director, Headquarters US Air Force Flight Standards Agency, US DoD.
Frequentis: weekly performance: -2.19%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (10/01/2024)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #774: ATX vor US-Wahl etwas fester, Post brav, Volumina Wien nach 10 Mon. 2024 über 2023 gesamt, Austria Tabak




 

Bildnachweis

Aktien auf dem Radar:Agrana, Pierer Mobility, Warimpex, Immofinanz, CA Immo, Semperit, Bawag, EVN, OMV, Mayr-Melnhof, Linz Textil Holding, Josef Manner & Comp. AG, Wolford, Zumtobel, Oberbank AG Stamm, Polytec Group, Amag, Erste Group, EuroTeleSites AG, Flughafen Wien, Frequentis, Österreichische Post, Rosenbauer, S Immo, Telekom Austria, Uniqa, VIG, Wienerberger, Henkel, Hannover Rück, Volkswagen Vz..


Random Partner

Raiffeisen Zertifikate
Raiffeisen Zertifikate ist der führende österreichische Anbieter, der mit über 5.000 Anlage- und Hebelprodukten seit mehr als 20 Jahren in der DACH-Region genauso wie in vielen Märkten Zentral- und Osteuropas zu Hause ist. Einfach kompetent und schnell Marktentwicklungen handelbar zu machen, dafür steht Raiffeisen Zertifikate - Egal ob auf Aktien, Aktien-Indizes, Rohstoffe oder einzelne Themen basierend. Raiffeisen Zertifikate ist eine Marke der Raiffeisen Bank International AG.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten